We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Events

05 Aug 2026 - 07 Aug 2026
18 Aug 2026 - 20 Aug 2026

New Company To Promote and Commercialize bioMerieux Range in Japan

By HospiMedica staff writers
Posted on 22 Jan 2008
Sysmex Corp. More...
(Kobe, Japan; www.sysmex.com) and bioMerieux (Marcy l'Etoile, France; www.biomerieux.com) have signed an agreement to form a new company called Sysmex bioMerieux, Ltd. The company will promote and commercialize the entire bioMerieux product range in Japan.

bioMerieux has been operating in the Japanese clinical diagnostics and industrial testing market through bioMerieux Japan, Ltd., a fully owned subsidiary. The joint venture (JV) will manage the regulatory filing and marketing activities of bioMerieux product ranges in Japan. The sales and customer service activities will be contracted out from the JV to Sysmex.

Sysmex and bioMerieux have been developing their global partnership since July 2007, when bioMerieux became a global partner to distribute Sysmex's highly standardized and automated UF-1000i urine sediment analyzer to their extensive clinical microbiology customer base.

bioMérieux provides diagnostic products (reagents, instruments, software), which determine the source of disease and contamination to improve patient health and ensure consumer safety. Its products are used for diagnosing infectious diseases and providing high medical value results for cardiovascular emergencies and cancer screening and monitoring. They are also used for detecting microorganisms in agri-food, pharmaceutical, and cosmetic products.

Sysmex performs clinical laboratory testing of blood, urine, and other specimens, providing instruments and reagents for clinical laboratory testing as well as laboratory information systems. The company, which specialized in hematology, has expanded to offer a comprehensive range of diagnostics products and solutions in the diagnostics field including coagulation, biochemistry, immunochemistry, urinalysis, and other disciplines.

The market volume of microbiology testing in Japan is estimated at approximately US$280 million per year and is regarded as a strategically important market, the second largest in size worldwide.


Related Links:
Sysmex Corporation
bioMerieux

Gold Member
12-Channel ECG
CM1200B
Biochip Array Technology
Evidence MultiSTAT Drugs of Abuse Urine Multiplex Panel
Immobilization System
Cranial 4Pi Immobilization
Pediatric Mask
Respire SOFT
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image Credit: 123RF

Existing Cardiovascular Risk Calculators Predict Several Common Cancers

Cardiovascular risk calculators are embedded in primary and secondary care to estimate 10‑year risk of heart attack or stroke from factors such as age, body mass index, and smoking. Many of these same... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.